C23H32O6
Neat
404.51
+5°C
Room Temperature
1250-97-1; epi-Hydrocortisone acetate; SO6X7W9IAN; RefChem:1049325; (11alpha)-21-(Acetyloxy)-11, 17-dihydroxypregn-4-ene-3, 20-dione; 215-008-1; 11alpha, 17, 21-Trihydroxypregn-4-ene-3, 20-dione 21-acetate; Epi Hydrocortisone 21-Acetate; Hydrocortisone Acetate EP Impurity F; Epihydrocortisone 21-acetate; [2-[(8S, 9S, 10R, 11R, 13S, 14S, 17R)-11, 17-dihydroxy-10, 13-dimethyl-3-oxo-2, 6, 7, 8, 9, 11, 12, 14, 15, 16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate; (11alpha)-21-(Acetyloxy)-11, 17-dihydroxypregn-4-ene-3, 20-dione; Pregn-4-ene-3, 20-dione, 11alpha, 17, 21-trihydroxy-, 21-acetate (7CI, 8CI); Progesterone, 11alpha, 17, 21-trihydroxy-, 21-acetate (6CI); 21-Acetoxy-11alpha, 17-dihydroxypregn-4-ene-3, 20-dione; Epihydrocortisone 21-acetate; EINECS 215-008-1; UNII-SO6X7W9IAN; DTXSID80858940; FE22707; NS00081182; HYDROCORTISONE ACETATE IMPURITY F [EP IMPURITY]; 21-ACETOXY-11.ALPHA., 17-DIHYDROXYPREGN-4-ENE-3, 20-DIONE; PROGESTERONE, 11.ALPHA., 17, 21-TRIHYDROXY- and 21-ACETATE
[2-[(8S, 9S, 10R, 11R, 13S, 14S, 17R)-11, 17-dihydroxy-10, 13-dimethyl-3-oxo-2, 6, 7, 8, 9, 11, 12, 14, 15 and 16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
InChI=1S/C23H32O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-18,20,26,28H,4-9,11-12H2,1-3H3/t16-,17-,18+,20+,21-,22-,23-/m0/s1